4.
肺癌患者化疗前后SAS得分与生活质量各条目得分的关系(Pearson线性相关分析)
The correlation between SAS scores and items of EORTC QLQ-C30 before and after chemotherapy of lung cancer patients (Pearson linear correlation)
| Before chemotherapy | After 2 cycles | After 4 cycles | |
| *P < 0.05; **P < 0.01. | |||
| Functioning scales | |||
| Physical | 0.047 | -0.006 | 0.161 |
| Role | 0.047 | -0.044 | -0.164 |
| Emotion | 0.095 | -0.196 | -0.078 |
| Cognitive | -0.057 | -0.183 | -0.066 |
| Social | 0.020 | -0.252 | 0.148 |
| Symptom scales | |||
| Fatigue | 0.157 | 0.341* | 0.417** |
| Pain | -0.003 | -0.003 | 0.102 |
| Nausea and vomiting | 0.001 | -0.036 | 0.158 |
| Specific items reflecting symptoms and economic conditions | |||
| Dyspnoea | 0.227 | 0.436* | 0.049 |
| Insomnia | 0.318* | 0.241 | 0.362** |
| Appetite loss | 0.117 | 0.066 | -0.037 |
| Constipation | -0.043 | 0.196 | 0.285* |
| Diarrhea | -0.062 | -0.138 | 0.173 |
| Financial impact | -0.011 | 0.091 | 0.341* |
| Global quality of life | -0.154 | -0.232 | 0.075 |